Biotech · Private company · San Francisco, CA, US

CellSight Technologies, Inc.

Track this companyFree. Adds CellSight Technologies, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials152 recruiting or active

Pipeline programs9From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline9

[18F]F AraGPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
[18F]F-AraGPhase 2 · Advanced Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
[18F]F-AraGPhase 2 · Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT BenefitClinicalTrials.gov · fetched Nov 12, 2026
[18F]F-AraG (2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguanine)Phase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
[18F]F-AraG (2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguanine)Phase 2 · HIV InfectionsClinicalTrials.gov · fetched Nov 12, 2026
[18F]F-ARAG PETPhase 2 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
[18F]F-Ara-GPhase 1 · Graft Versus Host DiseaseClinicalTrials.gov · fetched Nov 12, 2026
[18F]F-AraGPhase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
[18F]F-AraG PET Scan, baseline + post anti-PD-1 therapy.Phase 1 · Squamous Cell Carcinoma of the Head and NeckClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials15

[18F]-AraG PET Imaging in LA HNSCCEARLY_PHASE1 · NOT_YET_RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07168785 · fetched Nov 12, 2026
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAGPHASE2 · UNKNOWN · started Nov 1, 2023ClinicalTrials.gov NCT06107374 · fetched Nov 12, 2026
Test-retest Evaluation of [18F]F-AraG PETPHASE2 · UNKNOWN · started Oct 31, 2023ClinicalTrials.gov NCT06084806 · fetched Nov 12, 2026
A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid TumorsPHASE2 · TERMINATED · started Mar 1, 2022ClinicalTrials.gov NCT04260256 · fetched Nov 12, 2026
18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in LymphomaPHASE1 · TERMINATED · started Sep 28, 2021ClinicalTrials.gov NCT05096234 · fetched Nov 12, 2026
Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung CancerPHASE2 · UNKNOWN · started Apr 15, 2021ClinicalTrials.gov NCT04726215 · fetched Nov 12, 2026
Imaging Immune Activation in COVID-19PHASE2 · RECRUITING · started Apr 15, 2021ClinicalTrials.gov NCT04815096 · fetched Nov 12, 2026
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer PatientsEARLY_PHASE1 · COMPLETED · started Mar 31, 2021ClinicalTrials.gov NCT04678440 · fetched Nov 12, 2026
PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC)PHASE1 · TERMINATED · started Feb 1, 2021ClinicalTrials.gov NCT04524195 · fetched Nov 12, 2026
Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. NivolumabPHASE2 · COMPLETED · started Sep 2, 2020ClinicalTrials.gov NCT04401995 · fetched Nov 12, 2026
Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung CancerPHASE1 · UNKNOWN · started Jul 16, 2019ClinicalTrials.gov NCT04052412 · fetched Nov 12, 2026
Imaging Immune Activation in HIV by PET-MRPHASE2 · UNKNOWN · started Sep 21, 2018ClinicalTrials.gov NCT03684655 · fetched Nov 12, 2026
Detection of Graft Versus Host Disease With [18F]F-AraGPHASE1 · COMPLETED · started May 15, 2018ClinicalTrials.gov NCT03367962 · fetched Nov 12, 2026
Study to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN)PHASE1 · COMPLETED · started May 1, 2017ClinicalTrials.gov NCT03129061 · fetched Nov 12, 2026
[18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation TherapyPHASE1 · UNKNOWN · started May 1, 2017ClinicalTrials.gov NCT03142204 · fetched Nov 12, 2026

NIH awards2

Imaging intracerebral and systemic T cell immunity in patients with Alzheimer's disease using 18F-F-AraGFiscal year 2026 · $882.9KNIH RePORTER 5R44AG094397-02 · fetched Nov 12, 2026
Imaging intracerebral and systemic T cell immunity in patients with Alzheimer's disease using 18F-F-AraGFiscal year 2025 · $871.3KNIH RePORTER 1R44AG094397-01 · fetched Nov 12, 2026